Patents by Inventor Roger Gay
Roger Gay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11957754Abstract: Some aspects of this disclosure provide clinical media that support viability, re-plating efficiency, and repopulation capacity of cells and tissues during storage for up to 48 hours or longer. The clinical media provided herein are also useful for clinical irrigation. Cell or tissue preparations comprising a cell population or tissue and a clinical medium as provided herein are also provided, as are methods for generating such preparations. Methods for using the clinical media and cell and tissue preparations provided herein, for example, for administering an effective amount of cells or tissue to a subject in need thereof, are also disclosed.Type: GrantFiled: March 23, 2021Date of Patent: April 16, 2024Assignee: Astellas Institute for Regenerative MedicineInventors: Roger Gay, Judson Ratliff, Romma E. Southwick
-
Publication number: 20240026419Abstract: Methods are provided for detection of a target cell type within a cell population, and compositions are provided comprising cells and an indicator that indicates the number of cells of the target cell type in the cell population. Examples are provided in which these methods are used to detect human embryonic stem cells within a differentiated cell population with exquisite sensitivity. Differentiated cells produced from embryonic stem cells can be characterized by these methods before transplantation into a recipient, thereby providing further assurance of safety.Type: ApplicationFiled: July 6, 2023Publication date: January 25, 2024Applicant: Astellas Institute for Regenerative MedicineInventors: Irina Klimanskaya, Roger Gay
-
Publication number: 20230408489Abstract: This disclosure provides a new phagocytosis assay to test the function of RPE cells and photoreceptor progenitors using a pH sensitive fluorescent label.Type: ApplicationFiled: May 12, 2023Publication date: December 21, 2023Applicant: Astellas Institute for Regenerative MedicineInventors: Irina Klimanskaya, Julie Kathryn Carson, Roger Gay, Yordanka Gikova Ivanova
-
Patent number: 11739366Abstract: Methods are provided for detection of a target cell type within a cell population, and compositions are provided comprising cells and an indicator that indicates the number of cells of the target cell type in the cell population. Examples are provided in which these methods are used to detect human embryonic stem cells within a differentiated cell population with exquisite sensitivity. Differentiated cells produced from embryonic stem cells can be characterized by these methods before transplantation into a recipient, thereby providing further assurance of safety.Type: GrantFiled: July 25, 2011Date of Patent: August 29, 2023Assignee: Astellas Institute for Regenerative MedicineInventors: Irina V. Klimanskaya, Roger Gay
-
Patent number: 11680941Abstract: This disclosure provides a new phagocytosis assay to test the function of RPE cells and photoreceptor progenitors using a pH sensitive fluorescent label.Type: GrantFiled: August 15, 2022Date of Patent: June 20, 2023Assignee: Astellas Institute for Regenerative MedicineInventors: Irina Klimanskaya, Julie Kathryn Carson, Roger Gay, Yordanka Gikova Ivanova
-
Publication number: 20230051804Abstract: This disclosure provides a new phagocytosis assay to test the function of RPE cells and photoreceptor progenitors using a pH sensitive fluorescent label.Type: ApplicationFiled: August 15, 2022Publication date: February 16, 2023Applicant: Astellas Institute for Regenerative MedicineInventors: Irina Klimanskaya, Julie Kathryn Carson, Roger Gay, Yordanka Gikova Ivanova
-
Patent number: 11422125Abstract: This disclosure provides a new phagocytosis assay to test the function of RPE cells and photoreceptor progenitors using a pH sensitive fluorescent label.Type: GrantFiled: March 23, 2016Date of Patent: August 23, 2022Assignee: Astellas Institute for Regenerative MedicineInventors: Irina V. Klimanskaya, Julie Kathryn Carson, Roger Gay, Yordanka Gikova Ivanova
-
Publication number: 20210275673Abstract: Some aspects of this disclosure provide clinical media that support viability, re-plating efficiency, and repopulation capacity of cells and tissues during storage for up to 48 hours or longer. The clinical media provided herein are also useful for clinical irrigation. Cell or tissue preparations comprising a cell population or tissue and a clinical medium as provided herein are also provided, as are methods for generating such preparations. Methods for using the clinical media and cell and tissue preparations provided herein, for example, for administering an effective amount of cells or tissue to a subject in need thereof, are also disclosed.Type: ApplicationFiled: March 23, 2021Publication date: September 9, 2021Applicant: Astellas Institute for Regenerative MedicineInventors: Roger Gay, Judson Ratliff, Romma E. Southwick
-
Patent number: 11013808Abstract: Some aspects of this disclosure provide clinical media that support viability, re-plating efficiency, and repopulation capacity of cells and tissues during storage for up to 48 hours or longer. The clinical media provided herein are also useful for clinical irrigation. Cell or tissue preparations comprising a cell population or tissue and a clinical medium as provided herein are also provided, as are methods for generating such preparations. Methods for using the clinical media and cell and tissue preparations provided herein, for example, for administering an effective amount of cells or tissue to a subject in need thereof, are also disclosed.Type: GrantFiled: August 18, 2016Date of Patent: May 25, 2021Assignee: Astellas Institute for Regenerative MedicineInventors: Roger Gay, Judson Ratliff, Romma E. Southwick
-
Publication number: 20200405767Abstract: This disclosure provides the first description of hESC-derived cells transplanted into human patients. Results are reported for one patient with each of Stargardt's Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD). Controlled hESC differentiation resulted in near-100% pure RPE populations. Immediately after surgery, hyperpigmentation was visible at the transplant site in both patients, with subsequent evidence the cells had attached and integrated into the native RPE layer. No signs of inflammation or hyperproliferation were observed. The hESC-derived RPE cells have shown no signs of rejection or tumorigenicity at the time of this report. Visual measurements suggest improvement in both patients.Type: ApplicationFiled: July 13, 2020Publication date: December 31, 2020Applicant: Astellas Institute for Regenerative MedicineInventors: Roger Gay, Irina V. Klimanskaya, Robert P. Lanza
-
Publication number: 20190358330Abstract: Some aspects of this disclosure provide clinical media that support viability, re-plating efficiency, and repopulation capacity of cells and tissues during storage for up to 48 hours or longer. The clinical media provided herein are also useful for clinical irrigation. Cell or tissue preparations comprising a cell population or tissue and a clinical medium as provided herein are also provided, as are methods for generating such preparations. Methods for using the clinical media and cell and tissue preparations provided herein, for example, for administering an effective amount of cells or tissue to a subject in need thereof, are also disclosed.Type: ApplicationFiled: August 18, 2016Publication date: November 28, 2019Applicant: Astellas Institute for Regenerative MedicineInventors: Roger Gay, Judson Ratliff, Romma E. Southwick
-
Publication number: 20190030168Abstract: Some aspects of this disclosure provide clinical media that support viability, re-plating efficiency, and repopulation capacity of cells and tissues during storage for up to 48 hours or longer. The clinical media provided herein are also useful for clinical irrigation. Cell or tissue preparations comprising a cell population or tissue and a clinical medium as provided herein are also provided, as are methods for generating such preparations. Methods for using the clinical media and cell and tissue preparations provided herein, for example, for administering an effective amount of cells or tissue to a subject in need thereof, are also disclosed.Type: ApplicationFiled: August 18, 2016Publication date: January 31, 2019Applicant: Astellas Institute for Regenerative MedicineInventors: Roger Gay, Judson Ratliff, Romma E. Southwick
-
Publication number: 20180052150Abstract: This disclosure provides a new phagocytosis assay to test the function of RPE cells and photoreceptor progenitors using a pH sensitive fluorescent label.Type: ApplicationFiled: March 23, 2016Publication date: February 22, 2018Inventors: Irina V. Klimanskaya, Julie Kathryn Carson, Roger Gay, Yordanka Gikova Ivanova
-
Patent number: 9286574Abstract: A computer-implemented method for layered training of machine-learning architectures includes receiving a plurality of data elements wherein each data element is associated with a timestamp, determining a training window for each model layer of a layered stack of model layers, determining a plurality of training data elements for each training window by identifying the data elements with timestamps corresponding to each of the training windows, identifying a previous checkpoint for each model layer wherein the previous checkpoint for each model layer is generated by a parent model layer, training each model layer with the determined training data elements for each model layer and the identified previous checkpoint for each model layer, generating a plurality of current checkpoints wherein each current checkpoint of the plurality of current checkpoints is associated with a model layer, and storing the plurality of current checkpoints at the memory.Type: GrantFiled: November 4, 2013Date of Patent: March 15, 2016Assignee: Google Inc.Inventors: David Roger Gay, Paul Church, Russell O'Connor, Vinay Chaudhary, Yaroslav Litus
-
Publication number: 20150366915Abstract: This disclosure provides the first description of hESC-derived cells transplanted into human patients. Results are reported for one patient with each of Stargardt's Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD). Controlled hESC differentiation resulted in near-100% pure RPE populations. Immediately after surgery, hyperpigmentation was visible at the transplant site in both patients, with subsequent evidence the cells had attached and integrated into the native RPE layer. No signs of inflammation or hyperproliferation were observed. The hESC-derived RPE cells have shown no signs of rejection or tumorigenicity at the time of this report. Visual measurements suggest improvement in both patients.Type: ApplicationFiled: May 15, 2015Publication date: December 24, 2015Applicant: Ocata Therapeutics, Inc.Inventors: Roger Gay, Irina V. Klimanskaya, Robert P. Lanza
-
Publication number: 20150127590Abstract: A computer-implemented method for layered training of machine-learning architectures includes receiving a plurality of data elements wherein each data element is associated with a timestamp, determining a training window for each model layer of a layered stack of model layers, determining a plurality of training data elements for each training window by identifying the data elements with timestamps corresponding to each of the training windows, identifying a previous checkpoint for each model layer wherein the previous checkpoint for each model layer is generated by a parent model layer, training each model layer with the determined training data elements for each model layer and the identified previous checkpoint for each model layer, generating a plurality of current checkpoints wherein each current checkpoint of the plurality of current checkpoints is associated with a model layer, and storing the plurality of current checkpoints at the memory.Type: ApplicationFiled: November 4, 2013Publication date: May 7, 2015Applicant: Google Inc.Inventors: David Roger Gay, Paul Church, Russell O'Connor, Vinay Chaudhary, Yaroslav Litus
-
Publication number: 20130302824Abstract: Methods are provided for detection of a target cell type within a cell population, and compositions are provided comprising cells and an indicator that indicates the number of cells of the target cell type in the cell population. Examples are provided in which these methods are used to detect human embryonic stem cells within a differentiated cell population with exquisite sensitivity. Differentiated cells produced from embryonic stem cells can be characterized by these methods before transplantation into a recipient, thereby providing further assurance of safety.Type: ApplicationFiled: July 25, 2011Publication date: November 14, 2013Applicant: Advanced Cell Technology, Inc.Inventors: Irina Klimanskaya, Roger Gay